Johnson and Johnson Discontinuing Sales or Transvaginal Mesh

Johnson & Johnson (J&J) says it will discontinue sales of four of its transvaginal mesh products over the next several months. The company, along with several other device makers, is facing hundreds of lawsuits due to serious complications and injuries linked to the defective mesh. If you have been injured by J&J mesh or any other vaginal mesh product, please talk to our Louisiana drug recall attorneys right away.

 

Affected Products

J&J says it has asked the U.S. Food and Drug Administration (FDA) for permission to phase out sales of the following vaginal mesh products:

 

  • Gynecare Prolift
  • Gynecare Prolift+M
  • Gynecare TVT Secur
  • Gynecare Prosima

It has also asked to keep selling its Gynecare Gynemesh product, but with changes to the label restricting its use to abdominal, rather than transvaginal, placement only.

 

Not a Recall

J&J is not recalling units which have already been sold or implanted. The company says that the products are perfectly safe, and that the decision to discontinue sales is due to changes in commercial viability of the mesh. It plans to phase out sales, worldwide, over the next three to nine months and hopes to complete the process by the first quarter of 2013.

If you are a resident of Louisiana and have been harmed by defective vaginal mesh or lost a loved one to this dangerous medical device, please contact our Louisiana defective drug attorneys at 1-877-LOSS-RECOVER (567-7732). Our qualified and successful product liability lawyers will get you the money you deserve, so call our law firm today.